Regulatory News
Wednesday, July 27, 2016
UPDATE 3-GlaxoSmithKline invests $360 mln in UK despite Brexit vote
* UK accounts for nearly half GSK R&D, third manufacturing
(Adds proportion of GSK manufacturing and R&D carried out in
UK)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment